Skip to main content
. 2022 Oct 20;12:17545. doi: 10.1038/s41598-022-19848-4

Table 1.

Patient and eye characteristics.

AQP4-IgG+ MOG-IgG+ MS HC AQP4-IgG+ versus MOG-IgG+ AQP4-IgG+ versus MS AQP4-IgG+ versus HC
Subjects n 28 14 29 14
Sex Female N (%) 26 (92.9%) 7 (50%) 21 (72.4%) 10 (71.4%) < 0.01 0.08 0.16
Age [years] Median [Range] 49.5 [20–69] 46.0 [21–59] 39.4 [25–64] 41.7 [24–68] 0.52 0.01 0.43
EDSS  Median [Range] 3.75 [0.00–6.50] 2.50 [1.00–6.00] 2.00 [0.00–4.50] 0.06 < 0.01
Visual FS  Median [Range] 1.00 [0.00–6.00] 0.00 [0.00–3.00] 0.00 [0.00–5.00] 0.07 0.01
Eyes N 54 26 58 28 (−)
ON+ eyes NON 23 15 24

ON History

[Patients: NON/ON unilateral/ON bilateral]

NNON/NuniON/NbilON 12/9/7 4/5/5 10/14/5
No. of ON (by ON-eye) Median [Range] 2 [1–8] 2 [1–5] 1 [1, 2] 0.3 0.02
Years since first ON (by eye) Median [Range] 6.9 [0.8–28.1] 6.3 [0.8–42.6] 6.5 [0.6–43.0] 0.48 0.77
Years since last ON (by eye) Median [Range] 4.7 [0.3–28.1] 4.4 [0.3–39.6] 6.5 [0.3–43.0] 0.95 0.24

AQP4-IgG+ aquaporin-4 antibody seropositive patients, MOG-IgG+ myelin-oligodendrocyte-glycoprotein antibody seropositive patients, MS multiple sclerosis, HC healthy control, SD standard deviation, EDSS expanded disability status scale, FS functional system, ON optic neuritis.

P-values from Fischer´s Exact Test (sex ratio) or Mann–Whitney-U test (all other items); statistically significant results are printed in bold.